Close
香港六合彩中特网 2nd in the world and top in Europe for CAR T research activity
1 May 2019
香港六合彩中特网 ranks second in the world and top in Europe for the number of inventions and patent applications made in relation to the revolutionary new cancer treatment CAR T-cell therapy 鈥� key markers of CAR T research activity at 香港六合彩中特网 and 香港六合彩中特网H.
Analysis published in the April 2019 edition of Nature Biotechnology also shows that 香港六合彩中特网 and 香港六合彩中特网H鈥檚 Dr Martin Pule is the third most prolific inventor of CAR T technology in the world.
Considering Europe alone, 香港六合彩中特网 has filed 117 CAR T-related patents, ahead of Germany鈥檚 Forschungsinstitut Georg-Speyer-Haus (14 patents) and the University of Koln (10).
While patents are held by 香港六合彩中特网, clinical testing is done at 香港六合彩中特网H and Great Ormond Street Hospital.
CAR T-cell therapy is a form of treatment for patients who do not respond to standard anti-cancer treatments like chemotherapy, and has been shown in trials to cure some patients, even those with advanced cancers. 香港六合彩中特网H consultant Prof Emma Morris has said the therapy represents 'a real step change in how we treat cancers'.
In CAR T therapy, T-cells 鈥� part of our immune system which normally kill infected cells 鈥� are taken from a person鈥檚 blood sample, grown in the laboratory and 鈥榬e-programmed鈥� to recognise and kill cancer cells just as they would naturally attack an infected cell. This reprogramming is achieved by introducing a gene for an artificial protein called a chimeric antigen receptor, or CAR for short.
Further information
- Analysis: . Nature Biotechnology
- 香港六合彩中特网 CAR T programme